Related Experiment Video
Updated: Jul 20, 2026

Stereotactic Intracranial Implantation of Glioblastoma Patient-derived Xenograft Cell Lines in Mice
Published on: February 27, 2026
Intracranial hemangioblastomas: an institutional experience
Srinivas Dwarakanath1, Ashish Suri, Bhavani Shanker Sharma
1Department of Neurosurgery, Neurosciences Center, All India Institute of Medical Sciences, New Delhi, 110029, India.
Intracranial hemangioblastomas require lifelong surveillance for recurrence, particularly in patients with Von Hippel-Lindau (VHL) syndrome. This institutional review highlights key findings in managing these tumors.
Area of Science:
- Neurosurgery
- Neurology
- Oncology
Background:
- Intracranial hemangioblastomas are rare tumors.
- Von Hippel-Lindau (VHL) syndrome is a genetic disorder associated with hemangioblastomas.
Purpose of the Study:
- To present institutional experience with intracranial hemangioblastomas.
- To analyze patient demographics, tumor characteristics, treatment outcomes, and recurrence rates.
Main Methods:
- Retrospective study of 69 patients with intracranial hemangioblastomas.
- Data collected over an 11-year period (January 1992 - June 2003).
- Included patient demographics, tumor location, hydrocephalus, surgical interventions, and follow-up data.
Main Results:
- The average age at presentation was 34.5 years, with a male predominance (45 males, 24 females).
- Cerebellar hemispheres, vermis, and brainstem were common locations; 69% of patients had hydrocephalus.
- Mortality was 11%, and 15 patients experienced recurrent lesions during follow-up.
Conclusions:
- Surgical management is generally effective but associated with significant mortality.
- Lifelong surveillance is crucial for early detection of recurrences.
- VHL syndrome patients require particular attention for recurrent hemangioblastomas.
More Related Videos
09:18Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds
Published on: July 16, 2018
11:15Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018